Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
L9Y6vP4KcTbGUS4e